Product

GR2102

Aliases

GR2102 injection

1 clinical trial

1 indication

Indication

Respiratory Syncytial Virus Infections

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Single-dose Administration of GR2102 Injection in Healthy Adult Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Pharmacologic of GR2102

Status: Not yet recruiting, Estimated PCD: 2025-01-06